CH657531A5 - Pharmazeutische zusammensetzung zur perkutanen verabreichung. - Google Patents

Pharmazeutische zusammensetzung zur perkutanen verabreichung. Download PDF

Info

Publication number
CH657531A5
CH657531A5 CH245984A CH245984A CH657531A5 CH 657531 A5 CH657531 A5 CH 657531A5 CH 245984 A CH245984 A CH 245984A CH 245984 A CH245984 A CH 245984A CH 657531 A5 CH657531 A5 CH 657531A5
Authority
CH
Switzerland
Prior art keywords
atoms
alkyl
component
carbon atoms
formula
Prior art date
Application number
CH245984A
Other languages
German (de)
English (en)
Inventor
Jourge Heller
Wilfred A Skinner
Kenichiro Saito
Susumu Satoh
Yumiko Takakura
Yoshiaki Itoh
Original Assignee
Nitto Electric Ind Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Electric Ind Co filed Critical Nitto Electric Ind Co
Publication of CH657531A5 publication Critical patent/CH657531A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH245984A 1983-05-20 1984-05-18 Pharmazeutische zusammensetzung zur perkutanen verabreichung. CH657531A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49673283A 1983-05-20 1983-05-20

Publications (1)

Publication Number Publication Date
CH657531A5 true CH657531A5 (de) 1986-09-15

Family

ID=23973888

Family Applications (1)

Application Number Title Priority Date Filing Date
CH245984A CH657531A5 (de) 1983-05-20 1984-05-18 Pharmazeutische zusammensetzung zur perkutanen verabreichung.

Country Status (8)

Country Link
CA (1) CA1225594A (da)
CH (1) CH657531A5 (da)
DE (1) DE3418565C2 (da)
DK (1) DK239984A (da)
FR (1) FR2547503B1 (da)
GB (1) GB2141025B (da)
NL (1) NL8401422A (da)
SE (1) SE8402561L (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4637930A (en) * 1984-02-08 1987-01-20 Yamanouchi Pharmaceutical Co, Ltd. Transdermal formulation of nicardipine hydrochloride
JPS61280426A (ja) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
US4826686A (en) * 1985-12-14 1989-05-02 Boehringer Ingelheim Kg Therapeutic system
CH666621A5 (de) * 1986-06-27 1988-08-15 Ciba Geigy Ag Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.
US4861764A (en) * 1986-11-17 1989-08-29 Macro Chem. Corp. Percutaneous absorption enhancers, compositions containing same and method of use
GB8718886D0 (en) * 1987-08-10 1987-09-16 Ici America Inc Composition
CA1334646C (en) * 1988-04-08 1995-03-07 James Vanolden Peck Transdermal penetration enhancers
US5246949A (en) * 1989-12-06 1993-09-21 Sansho Co., Ltd. Preparation for endermism containing dopamine derivatives
JPH03236317A (ja) * 1989-12-06 1991-10-22 Sansei Seiyaku Kk ドパミン誘導体含有経皮用製剤
AU6410494A (en) * 1993-03-17 1994-10-11 Alza Corporation Device for the transdermal administration of alprazolam
DE4432429A1 (de) * 1994-09-12 1996-03-14 Heinz Prahm Arzneimittel enthaltend S-Milchsäure und dessen Verwendung
US5693335A (en) * 1995-06-07 1997-12-02 Cygnus, Inc. Skin permeation enhancer composition for use with sex steroids
DE19949202A1 (de) * 1999-10-13 2001-05-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Acetylsalicylsäure und/oder Salicylsäure
KR20080080087A (ko) * 2005-09-30 2008-09-02 티티아이 엘뷰 가부시키가이샤 신규 약학 담체를 이용한 경피 약물 전달시스템, 장치 및방법
WO2007079193A2 (en) 2005-12-30 2007-07-12 Tti Ellebeau, Inc. Iontophoretic systems, devices, and methods of delivery of active agents to biological interface

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1158283A (en) * 1965-10-21 1969-07-16 Foster Milburn Company Composition to be Applied to Skin and Process for Preparing Same.
FR2001768A1 (fr) * 1968-02-12 1969-10-03 Gillette Co Compositions pour l'application topique de medicaments sur la peau
SE325667B (da) * 1968-03-06 1970-07-06 Medisan Ab
US3472931A (en) * 1969-01-17 1969-10-14 Foster Milburn Co Percutaneous absorption with lower alkyl amides
GB1404583A (en) * 1971-10-08 1975-09-03 Vymatt Sa Urea compositions and methods of preparation thereof
GB1504302A (en) * 1974-08-23 1978-03-15 Fisons Ltd Sedative method and composition
US3957994A (en) * 1974-12-19 1976-05-18 Nelson Research & Development Company Topical anti-inflammatory composition and method of use
US3932653A (en) * 1974-12-19 1976-01-13 Nelson Research & Development Co. Composition and method for topical administration of griseofulvin
US4017641A (en) * 1975-01-31 1977-04-12 The Procter & Gamble Company Skin moisturizing compositions containing 2-pyrrolidinone
GB1538903A (en) * 1975-04-11 1979-01-24 Nelson Res & Dev Carrier for a topically applied physiologically active agent or cosmetic agent
US4316893A (en) * 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US4038417A (en) * 1975-06-19 1977-07-26 Nelson Research & Development Company Method for treatment of psoriasis
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion

Also Published As

Publication number Publication date
FR2547503A1 (fr) 1984-12-21
DE3418565A1 (de) 1984-11-22
GB2141025B (en) 1986-09-17
SE8402561L (sv) 1984-11-21
DK239984D0 (da) 1984-05-15
FR2547503B1 (fr) 1987-11-20
GB8412569D0 (en) 1984-06-20
DK239984A (da) 1984-11-21
NL8401422A (nl) 1984-12-17
GB2141025A (en) 1984-12-12
SE8402561D0 (sv) 1984-05-11
DE3418565C2 (de) 1992-05-27
CA1225594A (en) 1987-08-18

Similar Documents

Publication Publication Date Title
DE3424057C2 (de) Pharmazeutisches mittel zur perkutanen verabreichung
US4710497A (en) Method for percutaneously administering physiologically active agents
DE3503279C2 (da)
DE69206345T2 (de) Arzneimittel zur intranasalen Verabreichung, die Ketorolac R enthalten.
US4752612A (en) Method and percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
DE3787377T2 (de) Eindringungserhöhende mittel zur transdermalen verabreichung systemischer mittel.
CH657531A5 (de) Pharmazeutische zusammensetzung zur perkutanen verabreichung.
DE69613463T3 (de) Filmbildende pharmazeutische zusammensetzungen zur transdermalen verabreichung
DE3751761T2 (de) Penetrationsverbesserer für die transdermale Verabreichung von systemisch wirksamen Arzneimitteln
KR0143916B1 (ko) 약물/침투 증대제 조성물과 관련된 피부자극의 감소방법
DE60315939T2 (de) Pharmazeutische zusammensetzung enthaltend ein androgen
CH638402A5 (de) Verfahren zur herstellung eines pharmazeutikums fuer die einfuehrung in koerperoeffnungen.
DE69133042T2 (de) Lyophilisierte zubereitung sowie deren herstellung
DE69711237T2 (de) Lokalanästhetikum zur aüsserlichen anwendung
US5128376A (en) Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator
DE69332378T2 (de) Perkutan verabreichbare basiszusammensetzung und daraus hergestellte zusammensetzung
DE3424058C2 (de) Pharmazeutisches mittel zur perkutanen verabreichung
KR20020038595A (ko) 피부 침투제를 포함하는 국소용 제제 및 그의 용도
DE69008117T2 (de) Endermaler Arzneistoff in einer Gelbasis.
DE3689254T2 (de) Arzneimittel auf Dextrorphanbasis zur intranasalen Applikation.
DE3750264T2 (de) Durchdringungserhöhende mittel für transdermale verabreichung systemischer mittel.
DE3414377A1 (de) Arzneimittel, enthaltend meclofenaminsaeure, zur topischen anwendung
DE69623600T2 (de) Transdermale Zusammensetzungen enthaltend Nimesulide

Legal Events

Date Code Title Description
PL Patent ceased